Atlas Trials

Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.

Clinical trial NCT05106049 · UNKNOWN

Trial details

NCT number
NCT05106049
Sponsor
Assiut University
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-Alcoholic Fatty Liver Disease
Start date
2021-12-01
Primary completion
2022-12-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.